Vital Signs with Jacob Effron and Nikhil Krishnan by Redpoint Ventures

Jacob and Nikhil sit down with Dr. Atul Butte, a professor at UCSF, Chief Data Scientist of the UC Health System, and a co-founder of numerous healthcare startups. They discuss Dr. Butte’s takes on healthcare AI opportunities, challenges, hype, and more.

Jacob and Nikhil sit down with Dr. David Shulkin, the former Secretary of Veterans Affairs who has also held roles as CMO of the University of Pennsylvania Health System, CEO of Beth Israel Medical Center, and Vice Dean of the Drexel University College of Medicine. They discuss David’s experiences innovating within the VA, meeting the health needs of a population, and more.

Jacob and Nikhil sit down with Jean-Charles Samuelian-Werve, Co-Founder and CEO of Alan. Alan is a multi-billion dollar French health insurance company that has expanded to become an all-in-one health platform for its consumers. They discuss Alan’s product strategy and business model, building AI for healthcare companies, what healthcare looks like in Europe, and more.

Jacob and Nikhil sit down with Malay Gandhi, Head of Strategy & Corporate Development at Benchling. Malay previously served as CEO of Rock Health and SVP of Business Operations at Evidation Health, and his seminal pieces helped shape early digital health thinking. They discuss some of Malay’s early pieces, the future of life sciences & real-world evidence, building & scaling software at Benchling, and more.

Jacob and Nikhil sit down with Will Stokes, Co-Founder and Chief Growth Officer of Strive Health, a pioneer in value-based care that partners with payers and providers to care for patients with chronic kidney disease. They discuss the nuances of risk-based contracting, value-based models for specialists, selling to both payers and providers, and more.

Jacob sits down with Dr. Amy Abernethy, whose health tech career spans from clinician and researcher to CMO at Flatiron Health to Principal Deputy Commissioner and Chief Innovation Officer at the FDA to CMO and President of Product Development at Verily to co-founder of her own non-profit to accelerate evidence generation. They discuss the current and future states of real-world evidence, how clinical research can improve, the adoption of GenAI in healthcare, Verily’s growth story, her new venture, and more.